The top 10 pharma R&D budgets in 2019 Gilead builds case for filgotinib in active psoriatic arthritis AstraZeneca reportedly eyed a merger with Gilead. But does 'Gileaz' make sense? Alnylam paints fuller picture for kidney disease drug lumasiran with positive data 3 months after its B round, Akouos files an IPO to the tune of $100M BIO: Nimbus CEO: 'We're not just a one-hit wonder' Researchers find blood profile for screening severe COVID-19 cases from mild ones Featured Story | In 2019, the top 10 pharmaceutical R&D spenders collectively ploughed around $82 billion into their search for new drugs, diagnostics and vaccines, around $4 billion more than the previous year. EvaluatePharma has suggested that 2019 could represent a peak in R&D spend—at least as a proportion of pharmaceutical revenue. read more |
| |
|---|
|
Top Stories Monday, June 8, 2020 Gilead and Galapagos have presented long-term midphase data on filgotinib in patients with active psoriatic arthritis. The analysis shows responses seen at 16 weeks were sustained out to 52 weeks after the initiation of treatment. read more Monday, June 8, 2020 Six years ago, AstraZeneca CEO Pascal Soriot fought off Pfizer’s $118 billion takeover attempt. Now, the defender is reportedly playing offense, having approached Gilead Sciences to gauge its interest in a merger. But industry watchers don't see the deal happening. read more Sunday, June 7, 2020 With an FDA decision to come by the end of the year, Alnylam is offering a closer look at its RNA-silencing treatment for a rare kidney disorder. The drug, lumasiran, beat placebo at helping patients clear a substance called oxalate from their kidneys and lowered most patients’ oxalate levels to normal or near-normal amounts. read more Monday, June 8, 2020 Boston-based hearing loss gene therapy biotech Akouos is gunning for a $100 million IPO amid a near invulnerable market for public-seeking biotechs. read more Monday, June 8, 2020 When Nimbus Therapeutics set up shop in 2009, it had to convince the industry—including its founding chief scientific officer—that virtual drug discovery could be a viable approach. Now, Nimbus is unveiling four new programs it’s been working on, which could lead to treatments for metabolic disorders, cancer and autoimmune disease. read more Monday, June 8, 2020 A simple blood test may be able to help clinicians understand why one patient with COVID-19 may develop severe, life-threatening complications while another may show barely any symptoms at all. read more | | Your product is important, and your trial deserves the team that has what it takes. It takes knowledge. It takes passion. It takes commitment. It Takes Avania. Learn more. |
Enrollment Showcase | Sponsored by: University of Florida College of Pharmacy Position yourself as a precision medicine leader with the online graduate program in precision medicine. Learn the latest in genomic technologies and precision medicine therapies from experts in research and implementation. Join the future of health care with the flexibility and convenience of an online program. |
| |
|---|
|
Resources Sponsored by: ICON Download this whitepaper to learn more about the success factors that are required to keep a pandemic respiratory vaccine trial running at optimal speed and efficiency. Sponsored by: Catalent In a series of innovation sessions, Catalent RP Scherer softgel capsules were quickly identified as the ideal solution to drive incremental growth. Learn more. Sponsored by: Blue Matter, strategic consultants in the life sciences White paper describing 7 keys to success for any biopharma company that is entering (or thinking about entering) Europe. Sponsored by: Clinical Ink This white paper covers a Phase III case study; BYOD advantages and misconceptions; and regulatory, copyright, and equivalency considerations. Sponsored by: Clinical Ink Learn how GI specific data capture solutions can support virtual and hybrid trials during COVID-19. Sponsored by: Copyright Clearance Center Dive into the history of biomedical classification and how these systems have evolved to address new technology and use cases. Presented by: ICON Clinical Research Download this whitepaper to learn more about the success factors that are required to keep a pandemic respiratory vaccine trial running at optimal speed and efficiency. Sponsored by: Catalent Learn about a real-world example of how clinical supply management expertise was applied to overcome inventory challenges for a complex, global study. Sponsored by: Catalent Whether a study is simple or highly complex, forecasting and simulation reports serve as data driven communication tools to help minimize risks and keep the study on track. Learn more about forecasting solutions for informed decision making and supporting contingency planning for clinical study. Sponsored by: Catalent Learn how to drive excellence within the forecasting process and utilize forecasting throughout the clinical study to better plan clinical supply budgets and project timelines. Explore how to identify potential supply-related issues before they can negatively impact your study. Sponsored by: Clarify Health Pharma launch teams spend significant resources on data and analytics with limited ROI. Read this case study to learn how a Life Sciences company identified two times more patients best suited for therapy, using Clarify’s deep and longitudinal patient and HCP insights. Sponsored by: Frontage Laboratories, Inc. Listen to our brand-new Frontage Laboratories podcast where you’ll take home tips for developing residual host cell proteins ELISA assay for biopharmaceutical products using commercial kits. Wednesday, May 20, 2020 | Time: 10am-3.30pm (BST) Join us for a day of discovery as global experts in Cardiology, Pharmacology and Diabetes discuss state of the art methods in early phase clinical research. Sponsored by: Oracle Health Sciences Patient-facing digital technologies are playing an important role in clinical trials for new drugs and medical devices, to the point where conducting virtual trials is becoming mainstream. But terms like remote trials, direct-to-patient trials, hybrid trials, decentralized trials, and more all add to the confusion of what makes a trial "virtual." Sponsored by: Outer Edge Technology Businesses must maintain pre-pandemic levels of productivity with smaller IT budgets. Learn why an effective Cloud Strategy is imperative for success in these unprecedented times. Medical Affairs Strategic Summit (MASS) East April 14-16, 2020 | New Brunswick, NJ European Healthcare Compliance Certificate Program June 2-5, 2020 | Paris, France PEGS Virtual Interactive Summit Virtual Event | June 2-26, 2020 BIO 2020 Now Fully Virtual: Announcing BIO Digital June 8-11, 2020 | Virtual Event Drug Development Boot Camp® 2020 November 18-19, 2020 | Register now! Pre-Boot Camp training is in session. | Take your new medicine development skills to the next level. | 